<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 9)*
Dotronix, Inc.
________________________________________________________________________________
(Name of Issuer)
Common Stock, $.05 par value
________________________________________________________________________________
(Title of Class of Securities)
258564 10 3
_______________________________________________________________
(CUSIP Number)
William S. Sadler, 160 First Street S.E., New Brighton, MN 55112
________________________________________________________________________________
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
December 24, 1997
_______________________________________________________________
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].
Check the following box if a fee is being paid with the statement [_]. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 4
<PAGE>
13D
CUSIP NO. 258564103
NAME OF REPORTING PERSON
1. S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William S. Sadler
###-##-####
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
3. SEC USE ONLY
4. SOURCE OF FUNDS*
PF
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
6. CITIZENSHIP OR PLACE OF ORGANIZATION
USA
7. SOLE VOTING POWER
1,216,889
NUMBER OF
SHARES
8. SHARED VOTING POWER
BENEFICIALLY
OWNED BY
EACH 9. SOLE DISPOSITIVE POWER
1,216,889
REPORTING
PERSON
10. SHARED DISPOSITIVE POWER
WITH
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,216,889
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 11 EXCLUDES CERTAIN SHARES*
[_]
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
30.1%
14. TYPE OF REPORTING PERSON*
IN
Page 2 of 4
<PAGE>
SCHEDULE 13D
This amendment No. 9 to Schedule 13D is being filed to reflect changes in the
amount and form of beneficial ownership of common stock of Dotronix, Inc.
Item 1. Security and Issuer.
This statement relates to the Common Stock, $.05 par value (the "Common Stock"),
of Dotronix, Inc. (the "Issuer"). The Issuer's principal executive offices are
located at 160 First Street S.E., New Brighton, Minnesota 55112.
Item 2. Identity and Background.
The undersigned, William S. Sadler, is the Chief Executive Officer of the Issuer
and his business address is set forth above. He is a United States citizen.
The undersigned, during the last five years, has not been convicted in a
criminal proceeding (excluding traffic violations or other similar misdemeanors)
and has not been a party to a civil proceeding of a judicial or administrative
body that resulted in judgment or final order regarding violations of federal or
state securities laws.
Item 3. Source and Amount of Funds or Other Consideration.
The amount of funds used by the undersigned in purchasing 20,000 shares of
Common Stock on December 24, 1997 was $19,199 and the source of such funds was
personal funds. None of such funds were borrowed or otherwise obtained for the
purpose of acquiring, holding, trading or voting the securities.
Item 4. Purpose of Transaction.
The purpose of the undersigned's acquistion of the shares of the Issuer is for
investment.
Item 5. Interest in Securities of the Issuer.
The undersigned beneficially owns 1,196,889 shares of Common Stock (including
(a) 512,089 shares of Common Stock directly owned and previously acquired, (b)
684,800 shares of Common Stock owned and previously acquired through Minnesota
River Aviation, of which the undersigned is the sole shareholder, and (c) the
20,000
Page 3 of 4
<PAGE>
shares of Common Stock purchased as reported hereby), which constitutes 30.1% of
the shares of Common Stock of the Issuer. This percentage is based upon the
denominator of 4,039,135 outstanding shares of Common Stock as of December 24,
1997. Except as otherwise noted above, the undersigned holds sole voting power
and power of disposition in connection with such shares.
Additionally, the undersigned's spouse owns 12,800 shares of Common Stock, for
which the undersigned disclaims beneficial ownership.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to
Securities of the Issuer.
Incorporated by reference to Amendment No. 3 to this Schedule 13D.
Item 7. Material to be filed as Exhibits.
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true and complete.
Dated: February 12, 1998
/s/ William S. Sadler
----------------------------
William S. Sadler
Page 4 of 4
